Programme Committee

  • Matthew Albert (Roche/Genentech, USA)
  • Phillip Dennis (AstraZeneca, USA)
  • Andreas Diefenbach (Charité – Universitätsmedizin Berlin, Germany)
  • Volkmar Nussler (CDDF/Tumor Center, Munich, Germany)
  • Giorgio Trinchieri (Center for Cancer Research/NCI/NIH, USA)
  • Heinz Zwierzina (CDDF/Innsbruck University Hospital, Austria)
  • Laurence Zitvogel (Gustave Roussy, France)